895234

AstraZeneca Pharmaceuticals LP — FEI 2518137

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 26, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wilmington, DE (United States)